default author photo

Francesca Micoli

GSK Vaccines Institute for Global Health

Avenue Fleming 20

Waver, 1300

Belgium

SCHOLARLY PAPERS

2

DOWNLOADS

205

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Efficacy, Safety, and Immunogenicity of the Shigella sonnei 1790GAHB GMMA Candidate Vaccine: Results from a Phase 2b Randomized, Placebo-Controlled Challenge Study in Adults

Number of pages: 33 Posted: 02 Mar 2021
Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, GSK Vaccines Institute for Global Health, GSK, GSK, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, Fondazione Toscana Life Sciences - Monoclonal Antibody Discovery Lab (MAD), Burnet Institute, GSK Vaccines Institute for Global Health and GSK Vaccines Institute for Global Health
Downloads 122 (588,531)

Abstract:

Loading...

Shigella sonnei, 1790GAHB vaccine, GMMA, human challenge study, controlled human infection model, shigellosis

2.

Development and Qualification of a Multiplexed Immunoassay to Assess the Immunogenicity of Shigella Vaccines

Number of pages: 34 Posted: 24 Sep 2025
Gates Medical Research Institute, Gates Medical Research Institute, Hogrefe Consulting, Inc., VisMederi SRL, VisMederi SRL, VisMederi SRL, VisMederi SRL, GSK Vaccines Institute for Global Health, GlaxoSmithKline - Vaccines, GSK Vaccines Institute for Global Health, Luminex Corporation, World Health Organization (WHO) - Department of Immunizations, Vaccines and Biologicals, Gates Medical Research Institute, LimmaTech Biologics AG, LimmaTech Biologics AG, VisMederi SRL and Gates Medical Research Institute
Downloads 83 (783,685)

Abstract:

Loading...

Shigella, Lipopolysaccharide, Luminex, Immunoassay, Qualification